VRTX

Vertex Pharmaceuticals Incorporated · Healthcare · Biotechnology
$528.19
+12.64 (+2.45%)
Mkt Cap: 134.06B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield2.8%
Dividend YieldN/A
Market Cap134.06B
Volume1.50M
Recent News
Crinetics Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Crinetics Pharmaceuticals, Inc. - CRNX
gurufocus.com · 2026-08-17
Crinetics Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Crinetics Pharmaceuticals, Inc. - CRNX
businesswire.com · 2026-08-17
Vertex Pharmaceuticals Just Hit an All-Time High. Here's Why the Biotech Stock Could Soar Even More
fool.com · 2026-08-14
Vertex Pharmaceuticals: I Was Wrong About Its Near-Term Prospects (Rating Upgrade)
seekingalpha.com · 2026-08-14
Why Vertex Pharmaceuticals Stock Ticked Higher on Tuesday
fool.com · 2026-08-04
VRTX's Q2 Earnings Lag Estimates, Revenues Top, 2026 Sales View Raised
zacks.com · 2026-08-04

Unlock the Full Deep Scan

9 AI agents analyze VRTX across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →